Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose-Volume-Effect Correlation.

导出 OA

翻译打印收藏纠错

作者： Kim Melanie,Kraus ^[1] ; Caroline,Bauer ^[2] ; Benedikt,Feuerecker ^[3] ; Julius Clemens,Fischer ^[1] ; Kai Joachim,Borm ^[3] ; Denise,Bernhardt ^[4] ; Stephanie Elisabeth,Combs ^[5]

作者单位： Department of Radiation Oncology, School of Medicine and Klinikum Rechts der Isar, Technical University of Munich (TUM), 81675 Munich, Germany. ^[1] Institute of Radiation Medicine (IRM), Helmholtz Zentrum München (HMGU) GmbH, German Research Center for Environmental Health, 85764 Neuherberg, Germany. ^[2] Partner Site Munich and German Cancer Research Center (DKFZ), Heidelberg, German Cancer Consortium (DKTK), 80336 Munich, Germany. ^[3] Department of Radiology, School of Medicine and Klinikum Rechts der Isar, Technical University of Munich (TUM), 81675 München, Germany. ^[4] Department of Radiology, University Hospital Munich, LMU Munich, 81377 Munich, Germany. ^[5]

关键词 checkpoint inhibitors lung cancer radioimmunotherapy (RIT)stereotactic body radiation therapy (SBRT)

DOI 10.3390/cancers14122948

PMID 35740613

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交